Gaudinski, Martin R <br/><br/>
Safety and pharmacokinetics of the Fc-modified HIV-1 human monoclonal antibody VRC01LS: A Phase 1 open-label clinical trial in healthy adults.  [electronic resource] 

 -  PLoS medicine  01 2018 
 - e1002493 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article 
<br/><br/><label>ISSN: </label>1549-1676 
<br/><br/><label>Standard No.: </label>10.1371/journal.pmed.1002493  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antibodies, Monoclonal--adverse effects<br/>Antibodies, Neutralizing--immunology<br/>Antibody Formation<br/>Broadly Neutralizing Antibodies<br/>Dose-Response Relationship, Drug<br/>Female<br/>HIV Antibodies--immunology<br/>Half-Life<br/>Humans<br/>Infusions, Intravenous<br/>Infusions, Subcutaneous<br/>Male<br/>Middle Aged<br/>Young Adult